A Prospective Study on Helium-Based Plasma Radiofrequency for Minimally Invasive Breast Lift Scarless Mastopexy

Although mastopexy addresses breast ptosis, not all patients are willing or able to undergo surgery. Helium plasma radiofrequency (RF) is a minimally invasive alternative to traditional excisional breast lift surgery for mild-to-moderate breast ptosis.

To assess the efficacy and safety of helium plasma RF for minimally invasive mastopexy.

In this single-center prospective study, 15 patients were treated with helium plasma RF. Before and after photographs were assessed by blinded review 180 days postprocedure. Morphometric analysis and evaluations using investigator- and patient-assessed Global Aesthetic Improvement Scales (I-GAIS and P-GAIS, respectively) were carried out on posttreatment Days 30, 90, and 180. On Day 180, patients completed a satisfaction questionnaire and the Breast-Q scale.

At Day 180, the independent photographic review success rate was 73% (11/15). There was improvement in suprasternal notch to nipple distance (-1.2 ± 0.7 cm), midclavicular line to nipple distance (-0.9 ± 0.7 cm), and vertical distance from the suprasternal notch to the lowest point on the base (-1.5 ± 1.0 cm). Morphometric measurement appeared to improve over time, as did improvements in P-GAIS and I-GAIS. All patients (15/15) reported less sagging, higher appearance of breasts on the chest, improved nipple placement, more youthful-appearing breasts, and improved confidence and quality of life on the Breast-Q. There were no adverse events or pain reported during the procedure or follow-ups.

This study suggests that helium plasma RF is a well-tolerated and effective minimally invasive option for patients seeking an alternative to traditional breast lift surgery.